Open access
1,752
Views
4
CrossRef citations to date
0
Altmetric
Review Article
Immune checkpoint inhibitors of the PD-1/PD-L1-axis in non-small cell lung cancer: promise, controversies and ambiguities in the novel treatment paradigm
Lars H. Breimera Centre for Assessment of Medical Technology in Örebro, School of Health and Medical Sciences, Örebro University, Örebro University Hospital, Örebro, Sweden; ;b Department of Laboratory Medicine, Clinical Chemistry Division, Örebro University Hospital, Örebro, Sweden; Correspondence[email protected]
, Petros Nousiosa Centre for Assessment of Medical Technology in Örebro, School of Health and Medical Sciences, Örebro University, Örebro University Hospital, Örebro, Sweden;
, Louise Olssona Centre for Assessment of Medical Technology in Örebro, School of Health and Medical Sciences, Örebro University, Örebro University Hospital, Örebro, Sweden;
& Hans Brunnströmc Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden
Pages 360-369
|
Received 06 Dec 2019, Accepted 10 Mar 2020, Published online: 02 Apr 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.